|
| This article is part of the supplement: 17th Spring Meeting of the Association of Cardiothoracic AnaesthetistsMeeting abstractAcute normovolaemic haemodilution (ANH) is safe in patients with known coronary artery diseaseShackleton Department of Anaesthesia, Southampton General Hospital, Southampton, UK Cambridge, UK. 14 April 2000 Critical Care 2000, 4(Suppl C):4doi:10.1186/cc706
© 2000 Current Science Ltd IntroductionThe reduction of autologous blood transfusion is a national priority. The use of ANH as a blood conservation strategy remains controversial and under-investigated [1]. A recent paper [2] concluded that ANH should be avoided in patients with critical coronary stenosis or moderate-to-poor left ventricular function. There are no randomized controlled studies of the safety of ANH. ObjectivesTo investigate the safety of ANH using continuous Holter electrocardiography monitoring, serial analysis of daily postoperative electrocardiography, and by the use of troponin I levels. MethodsPatients presenting for elective coronary artery bypass surgery were randomized into a control or an ANH group. All patients had a four-lead Holter electrocardiography monitor attached 1 h before surgery. After a standard anaesthetic induction, patients in the ANH group had 10 ml/kg blood removed while being maintained within 20% of their baseline blood pressure. This blood was rein-fused after cardiopulmonary bypass. Troponin I levels were taken preoperatively, prebypass and at 24 h. All patients had daily postoperative electrocardiography analysis. ResultsThe results are shown in Table 1. ConclusionANH is safe. There is no evidence of an additional ischaemic burden after haemodilution. References
Have something to say? Post a comment on this article! |



on Google Scholar





